PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers model familial amyloidosis in vitro using iPSC technology

2013-10-31
(Press-News.org) Contact information: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Researchers model familial amyloidosis in vitro using iPSC technology (Boston) -- Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have generated the first known disease-specific induced pluripotent stem cell (iPSC) lines from a patient with familial transthyretin amyloidosis (ATTR). The findings, which are reported in Stem Cell Reports, may lead to new treatments for genetic diseases such as familial amyloidosis.

iPSCs are a form of stem cells that come from skin or blood cells reprogrammed into cells that have the ability to become any type of tissue in the body. ATTR is a lethal, autosomal dominant protein-folding disorder caused by one of more than 100 distinct mutations in the transthyretin (TTR) gene. In ATTR, protein secreted from the liver aggregates and forms fibrils in target organs, chiefly the heart and peripheral nervous system, highlighting the need for a model capable of duplicating the multisystem complexity of this clinically variable disease.

According to researchers using iPSC technology, cell lines can be established that are genetically identical to the individual from whom they are derived, allowing for disease modeling and development of novel therapeutics in the personalized genetic context of the patient from which they are made.

In this study, the researchers used the iPSC to generate liver cells that secrete the disease-specific mutant protein as well as cardiac and neuronal cells, the downstream target tissues of the disease. Upon exposure to the mutant protein, the heart and neuronal cells displayed signs of stress and an increased level of cell death as compared to those exposed to normal protein, thereby recreating essential aspects of the disease in vitro. Furthermore, small molecule stabilizers of the mutant protein that are being tested in clinical trials show efficacy in this model, validating this iPSC-based, patient-specific in vitro system as a platform for testing therapeutic strategies.

"Our work demonstrates that it is possible to model a complex, multisystem genetic disease in a relatively short space of time, using lineage-specified cells derived from patient stem cells," explained George J. Murphy, PhD, assistant professor of medicine in the section of Hematology and Oncology and co-director of the Center for Regenerative Medicine (CReM) at BUSM and BMC.

"This is a major breakthrough that will facilitate testing novel targeted therapies that are being developed for ATTR amyloidosis," said coauthor John Berk, MD, clinical director of the Amyloidosis Center at BUSM and BMC, where these rare diseases have been studied for more than 50 years. "Patients and families from all over the world who come to us for treatment may soon benefit from this research."

### Funding for the study was provided by the Amyloidosis Foundation, the Young Family Amyloid Research Fund and the Boston University Clinical and Translational Science Institute.


ELSE PRESS RELEASES FROM THIS DATE:

Study gives Catholic schools poor marks

2013-10-31
Study gives Catholic schools poor marks EAST LANSING, Mich. — A national study led by a Michigan State University economist suggests Catholic schools are not superior to public schools after all. Math scores for Catholic students dropped between kindergarten and eighth ...

Suzaku study points to early cosmic 'seeding'

2013-10-31
Suzaku study points to early cosmic 'seeding' Most of the universe's heavy elements, including the iron central to life itself, formed early in cosmic history and spread throughout the universe, according to a new study of the Perseus Galaxy Cluster ...

Researchers discover how retinal neurons claim the best brain connections

2013-10-31
Researchers discover how retinal neurons claim the best brain connections Discovery may shed light on brain disease, development of regenerative therapies Real estate agents emphasize location, location, and – once more for good measure – location. It's the same in a developing brain, ...

Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex

2013-10-31
Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex The supposedly widespread and variable Australasian liverwort species Radula buccinifera is nothing of the kind. The species was described in 1844, and reported for New Zealand in 1855. ...

Danish research provides new knowledge about the body's fight against HIV

2013-10-31
Danish research provides new knowledge about the body's fight against HIV When a person is infected with HIV the virus infects the cells of the immune system. From here the virus spreads around the body, while at the same time breaking down important ...

Patient in 'vegetative state' not just aware, but paying attention

2013-10-31
Patient in 'vegetative state' not just aware, but paying attention Research raises possibility of devices in the future to help some patients in a vegetative state interact with the outside world A patient in a seemingly vegetative state, unable to move or ...

Defective nanotubes turned into light emitters

2013-10-31
Defective nanotubes turned into light emitters UPV/EHU-University of the Basque Country researchers have developed and patented a new source of light emitter based on boron nitride nanotubes and suitable for developing high-efficiency optoelectronic devices This news ...

Scent marking

2013-10-31
Scent marking The mammalian equivalent of showy plumage Many animals use scent marking to advertise their territory – they urinate at strategic locations – to communicate their social status and ownership. It has ...

Research identifies ways to improve access to mental health services

2013-10-31
Research identifies ways to improve access to mental health services A study by researchers from the Universities of Liverpool and Manchester has identified ways to improve how older people and ethnic minority populations access mental health care services. As ...

Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant

2013-10-31
Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant DETROIT – New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threated by a recurrence of the disease, including some ...

LAST 30 PRESS RELEASES:

Pavlov’s dogs were conditioned to go to their treat. Why do some animals learn to interact with the bell instead?

Call for Young Editorial Board members at Current Molecular Pharmacology

MSU team develops scalable climate solutions for agricultural carbon markets

Playing an instrument may protect against cognitive aging

UNM study finds link between Grand Canyon landslide and Meteor Crater impact

Ultra-hot Jupiter’s death spiral could reveal stellar secrets

You only get one brain! The best helmet material for protecting your noggin

Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity

Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023

Research spotlight: New genetic roadmap offers insights into obesity and diabetes

Fred Hutch leads new Vanguard Study for Cancer Screening Research Network

‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds

New research helps narrow down uncertainties in near-term precipitation projections for the Asian Water Tower

AI tool accurately detects tumor location on breast MRI

Researchers use OCT imaging to uncover how the fallopian tube transports embryos

PolyU secures RGC theme-based research scheme funding to develop cost-effective and sustainable Co-GenAI model

Van Andel Institute scientists develop technique for high-resolution single cell epigenetic analysis

The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis

Review suggests ending adult boosters for tetanus, diphtheria

ESMT Berlin welcomes Rebecca Schaumberg to faculty

Blocking a little-known protein may offer new hope for devastating lung disease

Medieval medicine was smarter than you think – and weirdly similar to TikTok trends

FAU receives NIH grant to investigate amphetamine addiction

Realizing on-site carbon nanotube photo-thermoelectric imaging

Most of us love memes. But are they a form of comics?

Novel biosensor allows real-time monitoring of sucrose uptake in plants

Korea University researchers reveal revealing how WEE1 drives cancer resistance to immunotherapy

Pusan National University researchers develop breakthrough deep learning model that enhances handheld 3D medical imaging

SLAS Discovery and SLAS Technology demonstrate research impact with 2024 impact factors

Disease-causing bacteria can deal with stink as long as they get a meal

[Press-News.org] Researchers model familial amyloidosis in vitro using iPSC technology